Ex vivo infection of human embryonic spinal cord neurons prior to transplantation into adult mouse cord

Gábor Márton, Dóra Tombácz, J. Tóth, András Szabó, Z. Boldogkői, Ádám Dénes, A. Hornyák, Antal Nógrádi

Research output: Contribution to journalArticle

Abstract

Background: Genetically modified pseudorabies virus (Prv) proved suitable for the delivery of foreign genes to rodent embryonic neurons ex vivo and maintaining foreign gene expression after transplantation into spinal cord in our earlier study. The question arose of whether human embryonic neurons, which are known to be more resistant to Prv, could also be infected with a mutant Prv. Specifically, we investigated whether a mutant Prv with deleted ribonucleotide reductase and early protein 0 genes has the potential to deliver marker genes (gfp and β-gal) into human embryonic spinal cord neurons and whether the infected neurons maintain expression after transplantation into adult mouse cord.Results: The results revealed that the mutant Prv effectively infected human embryonic spinal cord neurons ex vivo and the grafted cells exhibited reporter gene expression for several weeks. Grafting of infected human embryonic cells into the spinal cord of immunodeficient (rnu-/rnu-) mice resulted in the infection of some of the host neurons.Discussion: These results suggest that Prv is suitable for the delivery of foreign genes into transplantable human cells. This delivery method may offer a new approach to use genetically modified cells for grafting in animal models where spinal cord neuronal loss or axon degeneration occurs.

Original languageEnglish
Article number65
JournalBMC Neuroscience
Volume11
DOIs
Publication statusPublished - May 29 2010

Fingerprint

Suid Herpesvirus 1
Spinal Cord
Transplantation
Neurons
Infection
Genes
Ribonucleotide Reductases
Gene Expression
Reporter Genes
Axons
Rodentia
Animal Models
Proteins

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Neuroscience(all)

Cite this

Ex vivo infection of human embryonic spinal cord neurons prior to transplantation into adult mouse cord. / Márton, Gábor; Tombácz, Dóra; Tóth, J.; Szabó, András; Boldogkői, Z.; Dénes, Ádám; Hornyák, A.; Nógrádi, Antal.

In: BMC Neuroscience, Vol. 11, 65, 29.05.2010.

Research output: Contribution to journalArticle

Márton, Gábor ; Tombácz, Dóra ; Tóth, J. ; Szabó, András ; Boldogkői, Z. ; Dénes, Ádám ; Hornyák, A. ; Nógrádi, Antal. / Ex vivo infection of human embryonic spinal cord neurons prior to transplantation into adult mouse cord. In: BMC Neuroscience. 2010 ; Vol. 11.
@article{e25c960e95ef433097449e2cf76590b0,
title = "Ex vivo infection of human embryonic spinal cord neurons prior to transplantation into adult mouse cord",
abstract = "Background: Genetically modified pseudorabies virus (Prv) proved suitable for the delivery of foreign genes to rodent embryonic neurons ex vivo and maintaining foreign gene expression after transplantation into spinal cord in our earlier study. The question arose of whether human embryonic neurons, which are known to be more resistant to Prv, could also be infected with a mutant Prv. Specifically, we investigated whether a mutant Prv with deleted ribonucleotide reductase and early protein 0 genes has the potential to deliver marker genes (gfp and β-gal) into human embryonic spinal cord neurons and whether the infected neurons maintain expression after transplantation into adult mouse cord.Results: The results revealed that the mutant Prv effectively infected human embryonic spinal cord neurons ex vivo and the grafted cells exhibited reporter gene expression for several weeks. Grafting of infected human embryonic cells into the spinal cord of immunodeficient (rnu-/rnu-) mice resulted in the infection of some of the host neurons.Discussion: These results suggest that Prv is suitable for the delivery of foreign genes into transplantable human cells. This delivery method may offer a new approach to use genetically modified cells for grafting in animal models where spinal cord neuronal loss or axon degeneration occurs.",
author = "G{\'a}bor M{\'a}rton and D{\'o}ra Tomb{\'a}cz and J. T{\'o}th and Andr{\'a}s Szab{\'o} and Z. Boldogkői and {\'A}d{\'a}m D{\'e}nes and A. Horny{\'a}k and Antal N{\'o}gr{\'a}di",
year = "2010",
month = "5",
day = "29",
doi = "10.1186/1471-2202-11-65",
language = "English",
volume = "11",
journal = "BMC Neuroscience",
issn = "1471-2202",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Ex vivo infection of human embryonic spinal cord neurons prior to transplantation into adult mouse cord

AU - Márton, Gábor

AU - Tombácz, Dóra

AU - Tóth, J.

AU - Szabó, András

AU - Boldogkői, Z.

AU - Dénes, Ádám

AU - Hornyák, A.

AU - Nógrádi, Antal

PY - 2010/5/29

Y1 - 2010/5/29

N2 - Background: Genetically modified pseudorabies virus (Prv) proved suitable for the delivery of foreign genes to rodent embryonic neurons ex vivo and maintaining foreign gene expression after transplantation into spinal cord in our earlier study. The question arose of whether human embryonic neurons, which are known to be more resistant to Prv, could also be infected with a mutant Prv. Specifically, we investigated whether a mutant Prv with deleted ribonucleotide reductase and early protein 0 genes has the potential to deliver marker genes (gfp and β-gal) into human embryonic spinal cord neurons and whether the infected neurons maintain expression after transplantation into adult mouse cord.Results: The results revealed that the mutant Prv effectively infected human embryonic spinal cord neurons ex vivo and the grafted cells exhibited reporter gene expression for several weeks. Grafting of infected human embryonic cells into the spinal cord of immunodeficient (rnu-/rnu-) mice resulted in the infection of some of the host neurons.Discussion: These results suggest that Prv is suitable for the delivery of foreign genes into transplantable human cells. This delivery method may offer a new approach to use genetically modified cells for grafting in animal models where spinal cord neuronal loss or axon degeneration occurs.

AB - Background: Genetically modified pseudorabies virus (Prv) proved suitable for the delivery of foreign genes to rodent embryonic neurons ex vivo and maintaining foreign gene expression after transplantation into spinal cord in our earlier study. The question arose of whether human embryonic neurons, which are known to be more resistant to Prv, could also be infected with a mutant Prv. Specifically, we investigated whether a mutant Prv with deleted ribonucleotide reductase and early protein 0 genes has the potential to deliver marker genes (gfp and β-gal) into human embryonic spinal cord neurons and whether the infected neurons maintain expression after transplantation into adult mouse cord.Results: The results revealed that the mutant Prv effectively infected human embryonic spinal cord neurons ex vivo and the grafted cells exhibited reporter gene expression for several weeks. Grafting of infected human embryonic cells into the spinal cord of immunodeficient (rnu-/rnu-) mice resulted in the infection of some of the host neurons.Discussion: These results suggest that Prv is suitable for the delivery of foreign genes into transplantable human cells. This delivery method may offer a new approach to use genetically modified cells for grafting in animal models where spinal cord neuronal loss or axon degeneration occurs.

UR - http://www.scopus.com/inward/record.url?scp=77954069418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954069418&partnerID=8YFLogxK

U2 - 10.1186/1471-2202-11-65

DO - 10.1186/1471-2202-11-65

M3 - Article

C2 - 20509957

AN - SCOPUS:77954069418

VL - 11

JO - BMC Neuroscience

JF - BMC Neuroscience

SN - 1471-2202

M1 - 65

ER -